- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Efficacy of a T Cell-Biased Adenovirus Vector as a Zika Virus Vaccine ; volume:8 ; number:1 ; day:20 ; month:12 ; year:2018 ; pages:1-10 ; date:12.2018
Scientific reports ; 8, Heft 1 (20.12.2018), 1-10, 12.2018
- Urheber
-
Bullard, Brianna L.
Corder, Brigette N.
Gorman, Matthew J.
Diamond, Michael S.
Weaver, Eric A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-35755-z
- URN
-
urn:nbn:de:101:1-2019020100263670799398
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bullard, Brianna L.
- Corder, Brigette N.
- Gorman, Matthew J.
- Diamond, Michael S.
- Weaver, Eric A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Development of a novel simian adenovirus 24 based vaccine vector
Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys
Adenovirus vaccine vectors : influence of vector tropism and vector directed immunity on adaptive immune responses to transgenic antigens
Construction and immune effect of an HPV16/18/58 trivalent therapeutic adenovirus vector vaccine
A Vaccine Based on a Modified Vaccinia Virus Ankara Vector Expressing Zika Virus Structural Proteins Controls Zika Virus Replication in Mice
Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine
Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation
A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses
Novel Adenovirus Vector-Based Vaccines for HIV
Zika vector transmission risk in temperate Australia: a vector competence study
Vaccine Development for Zika Virus—Timelines and Strategies
Immunogenicity of adenovirus-vector vaccine targeting hepatitis B virus: non-clinical safety assessment in non-human primates
Development of a novel simian adenovirus 24 based vaccine vector
Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys
Adenovirus vaccine vectors : influence of vector tropism and vector directed immunity on adaptive immune responses to transgenic antigens
Construction and immune effect of an HPV16/18/58 trivalent therapeutic adenovirus vector vaccine
A Vaccine Based on a Modified Vaccinia Virus Ankara Vector Expressing Zika Virus Structural Proteins Controls Zika Virus Replication in Mice
Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine
Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation
A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses
Novel Adenovirus Vector-Based Vaccines for HIV
Zika vector transmission risk in temperate Australia: a vector competence study
Vaccine Development for Zika Virus—Timelines and Strategies
Immunogenicity of adenovirus-vector vaccine targeting hepatitis B virus: non-clinical safety assessment in non-human primates
Development of a novel simian adenovirus 24 based vaccine vector
Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys
Adenovirus vaccine vectors : influence of vector tropism and vector directed immunity on adaptive immune responses to transgenic antigens
Construction and immune effect of an HPV16/18/58 trivalent therapeutic adenovirus vector vaccine
A Vaccine Based on a Modified Vaccinia Virus Ankara Vector Expressing Zika Virus Structural Proteins Controls Zika Virus Replication in Mice
Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine
Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation
A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses
Novel Adenovirus Vector-Based Vaccines for HIV
Zika vector transmission risk in temperate Australia: a vector competence study
Vaccine Development for Zika Virus—Timelines and Strategies